Uncertainty swirls on just how effective policy competition between the EU and UK on these much-needed products will be.
Report on lessons from crisis includes—and ignites—some criticism.
Some new EU plans "fly in the face" of innovation, critics contend.
Advancing the concept of "health competencies" remains elusive.
More opinions enter the mix as EU launches legislation review.
US pharma industry handcuffed by restrictions, group argues.